Clinical Efficacy of Huanglian Ointment in the Treatment of Chronic Eczema

Objective:To investigate and analyze the clinical efficacy of Huanglian ointment in the treatment of chronic eczema.Methods:114 cases of chronic eczema patients admitted to the Department of Dermatology of our hospital from January 2023 to January 2024 were selected as the study subjects.They were divided into a study group(n=57)and a reference group(n=57)using the double-blind method.The study group was treated with dialyzed Huanglian ointment,while the reference group was treated with conventional treatment.Symptom scores,inflammatory levels,treatment effects,and immune indexes of the two groups were similar before treatment.Results:After treatment,the symptom scores of the study group were significantly lower than those in the reference group(P<0.05).Besides,the interleukin-2(IL-2),tumor necrosis factor-a(TNF-a),interferon-(IFN-),and other inflammatory indicators of the study group were significantly better than those of the reference group(P<0.05).The total efficacy of treatment in the study group was significantly higher than that in the reference group(P<0.05).Furthermore,after treatment,the immunity indexes such as CD3+,CD4+,and CD8+of the study group were significantly better than those of the reference group,(P<0.05).Conclusion:Huanglian ointment is extremely effective for treating chronic eczema so this treatment program should be popularized.

Low-dose intralesional injection of 5-fluorouracil and triamcinolone reduces tissue resident memory T cells in chronic eczema

BACKGROUND Tissue resident memory T(TRM)cells have been reported to play a significant role in the pathogenesis and relapse of chronic eczema.AIM To compare the efficacy and safety of the intralesional injection of 5-fluorouracil(5-FU)and triamcinolone(TA)with those associated with TA alone for the treatment of chronic eczema.METHODS A total of 168 patients were randomized to 5-FU+TA or TA groups and received a one-time intralesional injection of 5-FU+TA or TA only.Biopsies were collected before and 2 wk after treatment for evaluation of histopathological changes.All patients were followed up monthly for up to 1 year.RESULTS No serious adverse event was observed in either group.Although the mean atopic dermatitis severity index scores and effective rates were comparable between the two groups after 2 wk of treatment,the relapse rate was significantly lower in the 5-FU+TA group than in the TA group.Histological examination showed significantly fewer CD8^(+)and CD103^(+)T cells but not CD4^(+)T cells in the 5-FU+TA group.CONCLUSION One-time intralesional injection of 5-FU+TA is effective and safe for chronic eczema treatment and can further reduce the retention of T_(RM) cells in the lesional skin and the relapse rate of chronic eczema.

Research Progress of Cymbaria mongolica Maxim.in the Treatment of Chronic Eczema

Chronic eczema is a kind of skin disease which is difficult to treat.It is easy to occur repeatedly,and itching is intolerable during the attack,which seriously affects the daily life of patients.Through the review of the treatment of chronic eczema with Mongolian medicine Cymbaria mongolica Maxim.,it has the advantages of improving the cure rate and the quality of life,and reducing the recurrence rate,and so on,which provides a scientific basis for the promotion and further research of traditional Mongolian medicine Cymbaria mongolica Maxim.

Shizhenqing granule stimulates the hypothalamic-pituitary-adrenal axis and reduces serum pro-inflammatory factors in a rat model with chronic eczema

Objective:In this study,we examined the effects of Shizhenqing granule(SZQG)on hypothalamicpituitary-adrenal(HPA)axis and serum inflammatory factors in a rat model of chronic eczema,in order to explore the mechanism of action of SZQG in treatment of this disease.Methods:Sixty SpragueeDawley male rats were randomly divided into six groups(with 10 rats per group):blank group;model group;positive control group(prednisone);and the low-,medium-,and high-dose SZQG groups.Except for the blank group,rats in all other groups were treated with 2,4-dinitrochlorobenzene to induce chronic eczema.These rats were administered prednisone or SZQG for 7 consecutive days after successful establishment of the chronic eczema model,and samples were collected 12 h after the last administration.The degree of skin lesions and the changes in serum levels of corticotropin-releasing hormone(CRH),adrenocorticotropic hormone(ACTH),cortisol(CORT),interleukin(IL)-4,interferon(IFN)-g,IL-25,and IL-31 among the groups were compared.Results:SZQG effectively increased the levels of CRH,ACTH,and CORT,which decreased in the serum of rats with chronic eczema,stimulated the function of the HPA axis,and promoted the expression of glucocorticoids.SZQG reduced the serum levels of inflammatory factors including IL-4,IL-25 and IL-31,which were overexpressed in rats with chronic eczema,and increased those of anti-inflammatory factor IFN-g,thereby alleviating the inflammatory symptoms and itching,and ameliorating the clinical symptoms of chronic eczema.Conclusion:SZQG effectively alleviates skin lesions in the chronic eczema rat model by stimulating the function of the HPA axis.

Clinical efficacy of combined skin acupuncture and external washing therapy of Zhuang nationality medicine in the treatment of chronic eczema

To evaluate the clinical efficacy of combined skin acupuncture and external washing therapy of Zhuang nationality medicine in the treatment of chronic eczema.Methods:One hundred and twenty patients with chronic eczema were randomly divided into an experimental group(60 cases)and a control group(60 cases).The experimental group was treated with skin acupuncture combined with external washing therapy,and the control group was treated with externally applied mometasone furoate cream.The patients’symptoms and total severity were scored and analyzed before and after the 4-week treatment.The symptoms scored included:erythema,papule/hard swelling,epidermal exfoliation,mossy lesion,exudation/scab,and pruritus.Clinical efficacy and adverse reactions were compared before and after the 4-week treatment.Results:Scores for the different kinds of skin derogation,pruritus symptoms,the eczema area,and severity index(EASI)were all reduced after the treatments.Pruritus symptoms and EASI scores in the experimental group were lower than those of the control group(P<0.05).The total effective rate in the experimental group was 81.03%,which was much higher than the 61.11%in the control group(Z=-2.391,P=0.017).Conclusion:The clinical efficacy of combined skin acupuncture and external washing therapy of Zhuang nationality medicine in the treatment of chronic eczema was better than that of mometasone furoate cream.

Exploring the association between gastrointestinal heat retention syndrome and adult chronic eczema: A caseecontrol study

Objective:To investigate the association between gastrointestinal heat retention syndrome(GHRS)and adult chronic eczema.Methods:This caseecontrol study compared GHRS/GHRS accompanied by damp-heat syndrome(GHRSDHS)and other patient characteristics between subjects with(cases)and without chronic eczema(controls)to identify potential factors associated with this condition.Semi-structured questionnaires were used to collect data via face-to-face interviews.Participants were recruited from Dongzhimen Hospital affiliated with Beijing University of Chinese Medicine.A logistic regression analysis was performed on the collected data,and odds ratios(ORs)were calculated.Results:A total of 168 cases and 172 controls were recruited.Among the cases of adult chronic eczema,there were 79 subjects with GHRS and 68 with GHRS-DHS.Sex(P=.02,OR=0.54,95%confidence interval[CI]:0.32-0.91),GHRS(P=.04,OR=1.90,95%CI:1.02-3.51),GHRS-DHS(P<.001,OR=4.89,95%CI:2.36-10.15),high sweet food consumption(P=.04,OR=2.03,95%CI:1.03-3.97),and mental stress(P=.01,OR=2.37,95%CI:1.26-4.47)were each found to be associated with chronic eczema.Furthermore,GHRS had a weak positive correlation with eczema EASI severity as measured by the eczema area and severity index(EASI)(P=003).Conclusion:GHRS/GHRS-DHS may be associated with adult chronic eczema.In the future,prospective cohort studies with larger samples should be conducted to investigate the cause and effect association between GHRS and adult chronic eczema.

A Case of Invasive Pulmonary Aspergillosis Resulted from the Treatment of Chronic Eczema

This was an advanced male(87-year-old)with refractory chronic eczema for over 40 years,based on his allergic constitution,accompanied with chronic kidney disease due to primary hypertension(CKD,phase 3).It was so difficult to tolerate the severe itching that the glucocorticoids(GC)had to be applied to it,but some new-onset respiratory symptoms,such as cough,dyspnea after exertion etc.,occurred to this patient.Some classical IPA images were found on his pulmonary CT scanning,which were further comfirmed by the positive findings of GM-test,and then a final diagno­sis of IPA was accordingly established.Unfortunately,a persistent fever emerged after starting an antifungal therapy to the patient,and his IL-2 level was detected to be superhigh.As a response to allergic fever,GC was carefully given intravenously again to treat it,and it turned out to be totally improved since then;suggesting that systemic thinking(integrated with the other clinical evidences)is essential to diagnose IPA,and GC can also be used to improve its symptoms with the existence of antifungal therapy.

TREATMENT OF 40 CASES OF CHRONIC ECZEMA WITH POINT-INJECTION OF COMPOUND RADIX SALVIAE MILTIORRHIZAE INJECTION

The authors have used point-injection of compound Radix Salviae Miltiorrhizae Injection to treat 40 cases of chronic eczema and achieved a satisfactory therapeutic effect. The total effective rate was 95%.

Study on effect of Traditional Chinese Medicine Jianpi Chushi decoction and ointment on chronic eczema

Objective:To study the effects of Traditional Chinese Medicine Jianpi Chushi decoction and ointment on chronic eczema.Methods:DNCB acetone solution was used to sensitize the skin of back and ears of 36 rats in order to establish chronic eczema model.A total of 36 rats were divided into four groups of 9 randomly including oral medicine group,external inunctum group,combination therapy group,and model control group respectively.Besides,the blank group of 4 healthy rats were set.The oral medicine group was given Traditional Chinese Medicine Jianpi Chushi decoction [(Poria cocos,Chinese yam,Cortex dictamni,Zaocys dhumnade,Rhizoma atractylodis,Pericarpium citri reticulatae,Scutellaria baicalensis,Radix Sophorae Flavescentis,Raw Radix Paeoniae Alba,Licorice roots(Northwest Origin)] by gastric infusion(1.6 g/m L·5 m L/d); the external inunctum group was given Qingpeng ointment on the skin,the combination therapy group was given Jianpi Chushi decoction by gastric infusion and Qingpeng ointment combination therapy.The model control group was given normal saline(NS) of the same volume by gastric infusion and vaseline on skin.Continuous administration 15 d and stopped for 3 d.The thickness difference and weight difference of left and right ear of every group were measured and the degree of ear swelling were evaluated.The CD4^+ and CD8^+ content and the IL-2,IL-4 level of serum were detected,and the inflammatory cells counts of back skin were recorded.Results:After treatment,the degree of ear swelling of oral medicine group,external inunctum group and combination therapy group significant decreased compared with model control group(P<0.05).The CD4^+,CD8^+ cell content and IL-2 level of oral medicine group,external inunctum group,combination therapy group and model control group significant decreased compared with blank group,and IL-2 level and the inflammatory cells count increased.After 15 d of treatment,the CD4^+,CD8^+ cell content and IL-2 level of serum of oral medicine group,external inunctum group and combination therapy group raised and the IL-4 level and the inflammatory cells count had significant decreased compared with model control group,and the effect of combination therapy group was more obvious(P<0.05).Conclusions:Qral Jianpi Chushi decoction could treat chronic eczema effectively,and oral Chinese medicine combined with ointment could enhance and speed up the efficacy.

火针联合黄连膏包敷治疗慢性湿疹血虚风燥证的临床观察

目的观察火针联合黄连膏包敷治疗慢性湿疹血虚风燥证的临床疗效。方法将100例慢性湿疹血虚风燥证患者按照随机数字表法分为2组,对照组50例予局部火针方法治疗,治疗组50例在对照组基础上予黄连膏包敷方法治疗。2组均治疗4周。比较2组治疗前后湿疹面积及严重程度指数(EASI)评分、瘙痒程度评分、瘙痒频率评分,并统计2组疗效及复发率。结果治疗组总有效率96.00%(48/50),对照组总有效率82.00%(41/50),治疗组临床疗效优于对照组(P<0.05)。2组治疗后EASI各项评分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05)。2组治疗后瘙痒程度评分、瘙痒频率评分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05)。治疗组复发率低于对照组(P<0.05)。结论火针联合黄连膏包敷治疗慢性湿疹血虚风燥证患者效果显著,能够减轻患者的瘙痒症状,降低复发率,值得推广应用。

基于JAK1/STAT5信号通路探讨肤痒静凝胶治疗慢性湿疹作用机制

目的:探讨肤痒静凝胶对慢性湿疹大鼠模型蛋白酪氨酸激酶1(janus protein kinase 1,JAK1)/信号转导与转录激活子5(signal transducerand activator of transcription 5,STAT5)信号通路调控作用的分子机制。方法:将36只SPF级Wistar大鼠随机分为正常组、模型组、青鹏软膏组(2500 mg·kg^(-1)·d^(-1))、肤痒静凝胶低(0.08 g/g)、中(0.16 g/g)、高(0.32 g/g)剂量组。除正常组外,其余组大鼠均采用2,4-二硝基氯苯丙酮液背部诱导慢性湿疹样病变。造模3周后青鹏软膏组及肤痒静凝胶低、中、高剂量组分别涂抹相应药物治疗;模型组涂抹空白凝胶基质,每日1次,共2周,正常组不做处理。观察慢性湿疹大鼠背部皮损的严重程度和病理变化;Western blot法检测大鼠背部皮肤组织中磷酸化蛋白酪氨酸激酶1(p-JAK1)和磷酸化信号转导与转录激活子5(p-STAT5)蛋白表达;qRT-PCR法检测大鼠背部皮肤组织中胸腺基质淋巴细胞生成素(thymic stromallymphopietin,TSLP)、JAK1、STAT5、白细胞介素-10(IL-10)和IL-17 mRNA表达水平;酶联免疫吸附法(ELISA)测定大鼠血清中IL-4、IL-6、IL-10、IL-13和IL-17水平。结果:与正常组比较,模型组大鼠血清中IL-4、IL-6、IL-13和IL-17水平明显升高,IL-10水平明显降低(P<0.05),背部皮损组织中p-JAK1、p-STAT5蛋白和TSLP、JAK1、STAT5、IL-17 mRNA表达水平明显升高,IL-10 mRNA水平明显降低(P<0.05)。与模型组比较,青鹏软膏组、肤痒静凝胶低、中、高剂量组大鼠血清中IL-4、IL-6、IL-13和IL-17水平明显降低,IL-10水平明显升高(P<0.05),背部皮损组织中p-JAK1、p-STAT5蛋白和TSLP、JAK1、STAT5、IL-17 mRNA表达水平明显降低,IL-10 mRNA水平明显升高(P<0.05)。与肤痒静凝胶低、中剂量组比较,青鹏软膏组大鼠血清中IL-4、IL-6、IL-13和IL-17水平明显降低,IL-10水平明显升高(P<0.05),背部皮损组织中p-JAK1、p-STAT5蛋白和TSLP、JAK1、STAT5、IL-17 mRNA表达水平明显降低,IL-10 mRNA水平明显升高(P<0.05)。与青鹏软膏组比较,肤痒静凝胶高剂量组大鼠血清中IL-4、IL-6、IL-10、IL-13和IL-17水平无明显差异(P>0.05),背部皮损组织中p-JAK1、p-STAT5蛋白和TSLP、JAK1、STAT5、IL-10、IL-17 mRNA表达水平无明显差异(P>0.05)。结论:肤痒静凝胶可能通过调控JAK1/STAT5信号通路相关炎症因子、蛋白和基因的表达发挥治疗慢性湿疹的作用。

朱仁康运用滋阴除湿汤治疗慢性湿疹经验

本文对朱仁康教授运用滋阴除湿汤治疗慢性湿疹经验进行总结。朱仁康教授认为,湿疹发病不离湿邪,湿邪贯穿疾病各阶段。发作期以标实为主,风邪袭表,腠理疏松,营阴外泄,留滞为湿,风湿相结于皮腠;慢性期以阴虚为主,久病伤正,湿伏于里,营阴亏虚而外燥。朱仁康教授针对慢性湿疹营阴亏损、湿邪留恋的疾病特点,创立滋阴除湿汤,并强调营阴与湿邪同源异途,并存不悖,滋阴与除湿之法并用,使阴复而无助湿之弊,湿去而无伤阴之瑕,可取得满意疗效。

消银颗粒与他克莫司联合应用对慢性湿疹患者疼痛及免疫指标的改善

目的 探究消银颗粒与他克莫司联合应用对慢性湿疹患者疼痛及免疫指标改善效果。方法 选取2022年1月—2023年2月山东省荣军总医院收治的94例慢性湿疹患者为研究对象,以电脑随机分配法分为对照组、观察组,各47例。对照组应用他克莫司治疗,观察组应用消银颗粒联合他克莫司治疗。比较两组治疗效果、治疗前后中医证候积分、免疫功能及睡眠质量。结果 观察组治疗总有效率为95.74%,高于对照组的78.72%,差异有统计学意义(χ^(2)=6.114,P<0.05)。治疗后,观察组中医证候积分低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组CD4^(+)、CD4^(+)/CD8^(+)水平高于对照组,CD8^(+)水平低于对照组,差异有统计学意义(P均<0.05)。治疗后,观察组匹兹堡睡眠质量指数评分低于对照组,差异有统计学意义(P<0.05)。结论 对慢性湿疹患者实施他克莫司联合消银颗粒治疗,可提升治疗效果,降低中医证候积分,提升免疫功能,提高患者睡眠质量。

新安解燥汤加减联合中药浸泡治疗慢性手部湿疹临床研究

目的观察新安解燥汤加减联合中药浸泡治疗慢性手部湿疹的临床疗效。方法将60例慢性手部湿疹患者随机分为对照组和观察组,每组30例。对照组采用慢性手部湿疹外洗方浸泡后立即外用尿素乳膏,观察组在对照组基础上予以新安解燥汤加减治疗。分别比较治疗前、治疗4周后、治疗8周后两组患者手部湿疹严重指数(hand eczema severity index,HECSI)评分、瘙痒和疼痛的视觉模拟量表(visual analogue scale,VAS)评分以及皮肤病生活质量指数(dermatology life quality index,DLQI)评分,并评估临床疗效、不良反应及复发情况。结果两组患者治疗4周后HECSI评分、VAS评分、DLQI评分均显著低于治疗前(P<0.05),治疗8周后上述评分均显著低于治疗4周后(P<0.05),且观察组降低程度更明显(P<0.05)。观察组临床疗效优于对照组(P<0.05),且复发率更低(P<0.05),两组均无明显不良反应。结论新安解燥汤加减联合中药浸泡治疗慢性手部湿疹临床疗效确切。

急、慢性期湿疹患者细胞因子及淋巴细胞亚群的表达及与严重程度的相关性分析

目的分析急性期和慢性期湿疹患者细胞因子及淋巴细胞亚群的差异表达及与湿疹严重程度的相关性。方法回顾性收集2023年5月至2024年5月在南昌大学第一附属医院住院治疗的急性期和慢性期湿疹患者的临床特征,外周血嗜酸性粒细胞计数及细胞因子、淋巴细胞亚群水平,湿疹面积及严重程度指数(EASI评分)等资料。比较急性期和慢性期湿疹在嗜酸性粒细胞、细胞因子、淋巴细胞亚群、EASI评分之间的差异,分析嗜酸性粒细胞、细胞因子、淋巴细胞亚群和急性期、慢性期湿疹严重程度的相关性。结果急性期和慢性期湿疹患者嗜酸性粒细胞、IL-22、CD4^(+)T细胞计数比较差异有统计学意义(P<0.05)。相关性分析表明急性期湿疹中CD4^(+)T细胞与EASI评分呈正相关(r=0.236,P<0.05)。慢性期湿疹中嗜酸性粒细胞、IL-5、IL-10、IL-22与EASI评分呈正相关(r=0.338、0.267、0.271、0.228,P<0.05)。结论急性期与慢性期湿疹之间存在细胞因子及淋巴细胞亚群差异,异常指标可作为急性期与慢性期湿疹严重程度评估工具。

复方氟米松软膏联合本维莫德乳膏序贯治疗手部慢性湿疹临床观察

目的:观察复方氟米松软膏联合本维莫德乳膏治疗手部慢性湿疹的临床疗效。方法:将入选的80例手部慢性湿疹患者随机分成2组。治疗组(40例)均外用复方氟米松软膏联合本维莫德乳膏序贯治疗,具体方法为先外用复方氟米松软膏,2 min后再外用本维莫德乳膏,每日2次;1周后停用复方氟米松软膏,继续仅外用本维莫德乳膏,每日2次。对照组(40例)仅外用复方氟米松软膏,每日2次。两组患者疗程均4周,4周后观察所有患者临床症状及皮损恢复情况,并判定疗效。结果:2组患者治疗前性别构成基本一致,年龄、病程、手部湿疹严重程度指数(HECSI)评分比较,差异均无统计学意义(P>0.05)。治疗4周后,治疗组痊愈10例,显效22例,有效率为80.00%;对照组痊愈3例,显效20例,有效率为57.50%。2组有效率比较,差异有统计学意义(P<0.05)。结论:复方氟米松软膏联合本维莫德乳膏序贯治疗手部慢性湿疹具有较好的疗效。

盐酸左西替利嗪片内服与丙酸氟替卡松乳膏外用联合治疗慢性湿疹的效果与不良反应分析

目的探讨盐酸左西替利嗪片内服与丙酸氟替卡松乳膏外用联合治疗慢性湿疹的效果与不良反应。方法选择2022年3月至2023年3月我院收治的慢性湿疹患者160例,随机分为对照组和观察组各80例。对照组给予盐酸左西替利嗪片内服,观察组在对照组基础上给予丙酸氟替卡松乳膏外用。对比两组的临床疗效、临床症状消失时间、皮损情况和不良反应。结果观察组总有效率高于对照组(P<0.05)。观察组疼痛、肥厚、鳞屑、红斑消失时间短于对照组,治疗后皮损症状积分和皮损面积低于对照组(P<0.05)。两组的不良反应发生率比较无统计学差异(P>0.05)。结论盐酸左西替利嗪片内服与丙酸氟替卡松乳膏外用联合治疗慢性湿疹可显著提高临床疗效,加快患者临床症状消失,改善皮损情况,且安全性较高,值得临床推广应用。

火针治疗慢性湿疹Meta分析

目的系统评价火针治疗慢性湿疹的临床有效性,为临床合理治疗慢性湿疹提供循证依据。方法检索各文献数据库创库至今所有火针治疗慢性湿疹的相关临床文献,运用Rev Man 5.4.1软件,辅以STATA 12.0对其总有效率结局指标进行分析。结果12篇文献符合纳入标准,累计病例779例。系统评价提示,试验组与对照组差异有统计学意义(OR=3.85,95%CI[2.42,6.12],P<0.00001)。结论Meta分析结果表明,相较于常规西药治疗,火针治疗慢性湿疹的效果存在明显优势。然而纳入文献数量不足或质量欠佳,影响结果的论证强度,尚需要更多大样本、高质量、多中心的随机对照试验加强此结论。

基于数据挖掘的刘兰林教授运用温病学三焦理论辨治慢性难治性湿疹的用药规律

目的:运用数据挖掘技术研究刘兰林教授辨治慢性湿疹的用药规律。方法:收集整理刘兰林教授治疗慢性湿疹的105张门诊处方单,借助Microsoft Excel 2010、SPSS Statistics 22.0、SPSS Modeler 18.0计算机软件建立数据库并进行频数及聚类分析。结果:所收集的处方涉及中药147味,18类,使用频数≥20次的常用药物有牡丹皮、蝉蜕、白鲜皮等,清热药、利水渗湿药位居前2位,药性上寒温搭配,药味以甘、苦、辛为主,归经多入肝、胃、脾、肺经。聚类分析出牡丹皮、大青叶、生地黄、淡竹叶、水牛角、玄参、首乌藤,蝉蜕、防风、僵蚕、徐长卿等7种组合。结论:刘兰林教授以温病学三焦理论为指导,将慢性湿疹病机核心责之于湿热内蕴,外发肌肤,治疗遵循三焦辨治原则,治以清热祛湿,调畅气机,分消上中下三焦湿热之邪,酌情配以凉血散瘀,祛风通络之品,用药喜寒温搭配,甘苦合化及苦辛相伍,擅以犀角地黄汤、升降散、五苓散、四妙散等经典名方加减。

麻黄连翘赤小豆汤加减对慢性湿疹患者的临床疗效

目的探讨麻黄连翘赤小豆汤加减对慢性湿疹患者的临床疗效。方法195例患者随机分为中药组、西药组和联合组,每组65例,中药组给予麻黄连翘赤小豆汤加减,西药组给予盐酸左西替利嗪,联合组给予麻黄连翘赤小豆汤加减联合盐酸左西替利嗪,疗程3周。检测临床疗效、临床指标(EASI评分、DQOLS评分、中医证候评分、PINS)、皮肤生理功能指标(OCTS、TEWL、WCTC)、炎性因子(EOT、EOS、NK-κB、CCR3)、T淋巴细胞亚群(Treg、Th1、Th17、Th22)、p38MAPK信号通路指标(ERK1、ERK2、MEK1、MEK2)、复发率、不良反应发生率变化。结果联合组总有效率高于中药组、西药组(P<0.05),复发率更低(P<0.05)。治疗后,联合组EASI评分、中医证候评分、PINS、TEWL、炎性因子、Th1、Th17、Th22、p38MAPK信号通路指标低于其他2组(P<0.05),DQOLS评分、OCTS、WCTC、Treg更高(P<0.05)。中药组不良反应发生率低于其他2组(P<0.05)。结论基于“四位一体”疗法的麻黄连翘赤小豆汤加减可安全有效地减轻慢性湿疹患者皮损程度,提高皮肤生理功能,改善炎性因子、T淋巴细胞亚群水平,调节p38MAPK信号通路,联合盐酸左西替利嗪具有协同增效的作用。